Multi-year and multi-transponder contract demonstrates CANAL+ Group‘s long-term commitment to satellite and SES

LUXEMBOURG - Saturday, December 17th 2016 [ME NewsWire]

(BUSINESS WIRE)-- SES S.A. (Euronext Paris:SESG) (LuxX:SESG) and CANAL+ Group have confirmed today the signature of a long-term, multi-year, multi-transponder framework agreement for SES satellite capacity in both France and Africa. The contract conditions are beneficial to both parties, and reflect the volume, extended duration and payment terms.

"CANAL+ Group is a long-standing partner for SES, and we are committed to support our customer's strategy and business in established and emerging markets," said Ferdinand Kayser, Chief Commercial Officer of SES. "We are pleased that this contract demonstrates CANAL+’s long-term commitment to satellite and to SES.”

“Our long-term partnership with SES is an important element in our strategy to gr ... Read more »

COLOMBES, France - Tuesday, December 13th 2016 [ME NewsWire]

(BUSINESS WIRE)-- OT (Oberthur Technologies), a leading global provider of embedded security software products and services, today announced that following its selection by Italy’s Ministry of the Economy and Finance (MEF), it is deploying 20 million Citizen Services Cards (CNS) throughout the country.

CNS is the official Italian Health and Citizen Services Card providing citizens throughout Italy with convenient, secure access to a range of on-line and off-line health and government services. Thanks to its recognized know-how and as a key player on the identity and healthcare markets, OT is currently deploying in the field millions of dual interface Common Criteria certified cards, as well as the corresponding digital signature application. Furthermore, the OT solution is fully compliant with the Netlink (eHIC) European Union framework.

As the key supplier to the CNS initiative, OT is working ... Read more »

PARIS - Friday, December 16th 2016 [ME NewsWire]

(BUSINESS WIRE)-- The Bureau International des Expositions (BIE) has closed the candidature period for Specialised Expo 2022/23. Four countries have submitted competing bids to organise Specialised Expo 2022/23: the Republic of Poland, the United States of America, the Federative Republic of Brazil and the Republic of Argentina.

The 169 Member States of the BIE will elect the host country of Specialised Expo 2022/23 at the 162nd General Assembly in November 2017.

Poland’s bid is for a Specialised Expo in the city of Łódź between 15 June and 15 September 2022 under the theme “City Re:Invented.”

The United States’ bid is for a Specialised Expo in Minneapolis between 15 May and 15 August 2023 under the theme “Wellness and Well Being for All: Healthy People, Healthy Planet.” The United States is not a Member State of the BIE.*

Brazil’s bid is for a Specialis ... Read more »

INGELHEIM, Germany & INDIANAPOLIS - Friday, December 16th 2016 [ME NewsWire]

    In the EMPA-REG OUTCOME® trial Jardiance® reduced the risk of cardiovascular (CV) death by 38 percent vs placebo in patients with type 2 diabetes (T2D) and established CV disease when added to standard of care
    The Committee for Medicinal Products for Human Use (CHMP) recommends to update the existing label of Jardiance® (empagliflozin) for the treatment of adults with insufficiently controlled T2D
    This is the first time the CHMP supports the use of a diabetes treatment for its effect on both glycaemic control and CV events

(BUSINESS WIRE)-- The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) today adopted a positive opinion to update the Jardiance® (empagliflozin) label including a change to the indication statement. The CHMP recommends Jardiance® for the ... Read more »